Janel Meisel News Today

Jane L. Meisel, MD, shares information from a study that evaluated patient-reported perceptions of patient-provider communication in breast cancer care.

Jane L. Meisel, MD, discusses patient-reported perceptions of patient-provider communication in cancer care.

Jane L. Meisel, MD, discusses the importance of prioritizing patients’ toxicity concerns and quality of life in the management of breast cancer.

Jane L. Meisel, MD, highlighted patient-reported gaps in provider communication regarding treatment-related toxicities in metastatic breast cancer.

Jane L. Meisel, MD, discusses the rationale for evaluating communication challenges that currently exist between patients and their oncologists.

Jane L. Meisel, MD, discusses findings from a study of communication challenges that exist between health care providers and patients with metastatic breast cancer regarding treatment-related adverse effects.